Stay updated on Isatuximab/Len in MRD+ MM Clinical Trial
Sign up to get notified when there's something new on the Isatuximab/Len in MRD+ MM Clinical Trial page.

Latest updates to the Isatuximab/Len in MRD+ MM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNew sections for Contacts/Locations, Oversight, and Study Status were added to the record history, and a deletion was recorded for 2025-08-06.SummaryDifference0.6%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe history shows a new revision v3.4.2 added and an earlier revision v3.4.1 removed, along with a site-wide funding notice; these are administrative updates that do not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check33 days agoChange DetectedThe page now displays a government funding notice and a new revision tag indicating Version 3.4.1 (replacing 3.4.0). This is a site-wide metadata update that does not change trial data or the core record content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check40 days agoChange DetectedAdded 'Show glossary' option and color-coded highlights for additions and deletions in the record history. Updated the revision label from v3.3.4 to v3.4.0 and removed 'No FEAR Act data'.SummaryDifference1%

- Check54 days agoChange DetectedThe record history now lists revision v3.3.4 and no longer lists revision v3.3.3.SummaryDifference0.1%

- Check76 days agoChange DetectedA new Revision: v3.3.3 was added and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed as maintenance/versioning changes; these do not affect study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Isatuximab/Len in MRD+ MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab/Len in MRD+ MM Clinical Trial page.